BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 19, 2012
View Archived Issues
First clinical data disclosed on new beta-secretase 1 inhibitor for Alzheimer's disease
Read More
Researchers at Boehringer Ingelheim patent new CXCR2 receptor antagonists
Read More
Novel protein kinase inhibitors synthesized at Bayer Schering Pharma
Read More
Novel data disclosed on Esteve drugs for pain
Read More
Epizyme scientists disclose new DOT1-like protein inhibitors
Read More
New GlyT1 inhibitors presented
Read More
Novel neprilysin inhibitors discovered at Theravance
Read More
Taisho Pharmaceutical develops new orexin receptor antagonists
Read More
Abbott designs new antiviral agents
Read More
Amicus and GSK expand collaboration
Read More
Agios Pharmaceuticals patents novel PKM2 activators
Read More
Convergence Pharmaceuticals plans phase change for CNV-2197944
Read More
Novel product reduces accumulation of oligomeric beta-amyloid in brain
Read More
Chugai submits NDA for ibandronate sodium hydrate
Read More
Dosing begins in BB3 acute myocardial infarction study
Read More
AMAG Pharmaceuticals reports preliminary data from IDA-301 trial
Read More
First clinical trials assess TOL-101 for preventing kidney transplant rejection
Read More
Novavax and PATH partner to develop RSV vaccine for maternal immunization
Read More
Alexza reports on Adasuve MAA
Read More
Pluristem engages CPC for phase II trial of PLX-PAD
Read More
Sanofi enters collaboration with Brigham and Women's Hospital
Read More
Infinity Pharmaceuticals regains rights to PI3K, FAAH and early discovery programs
Read More
EMA to review MAA for bazedoxifene/conjugated estrogens
Read More
Royal Melbourne Institute of Technology to research use of BioDiem's LAIV for noninfluenza vaccines
Read More
Phase III trial of rebamipide ophthalmic suspension begins
Read More
New S100-A4-neutralizing antibody is a potential therapy and biomarker for cancer
Read More
Aeras and IAVI expand vaccine research partnership
Read More